Expression of human telomerase reverse transcriptase in thyroid follicular neoplasms: An immunohistochemical study

Endocrine Pathology

Volumn 16, Issue 3, 2005, Pages 211-217

  Wang, Sheng Lan ^a   Chen, Wan Tzu ^a   Wu, Ming Tsang ^a   Chan, Hon Man ^b   Yang, Sheau Fang ^a   Chai, Chee Yin ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Follicular adenoma; Follicular carcinoma; Human telomerase reverse transcriptase (hTERT); Immunohistochemistry; Thyroid

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA;

EID: 28044467535     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:16:3:211     Document Type: Article

References (31)

1. Alvarez-Nunez F, Mora J, Matias-Guiu X. Thyroid carcinomas of the follicular epithelium: tumor markers and oncogenes. Med Clin (Barc) 121:264-269, 2003.
2. Liou MJ, Chan EC, Lin JD, Liu FH, Chao TC. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Cancer Lett 191: 223-227, 2003.
3. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science 269:1236-1241, 1995.
4. Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785-795, 1997.
5. Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959, 1997.
6. Yan P, Benhattar J, Seelentag W, Stehle JC, Bosman FT. Immunohistochemical location of hTERT protein in human tissues. Histochem Cell Biol 121:391-397, 2004.
7. Martin JA, DeYoung BR, Gitelis S, et al. Telomerase reverse transcriptase subunit expression is associated with chondrosarcoma malignancy. Clin Orthop 426:117-124, 2004.
8. Lantuejoul S, Soria JC, Moro-Sibilot D, et al. Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours. Br J Cancer 90:1222-1229, 2004.
9. Malaska J, Kunicka Z, Borsky M, et al. Telomerase as a diagnostic and predictive marker in colorectal carcinoma. Neoplasma 51:90-96, 2004.
10. Hirokawa M, Carney JA, Goellner JR, et al. Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol 26:1508-1514, 2002.
11. Bodnar AG, Quellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352, 1998.
12. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature 400:464-468, 1999.
13. Jiang XR, Jimenez G, Chang E, et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 21:111-114, 1999.
14. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. Both Rb of p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396:84-88, 1998.
15. Bornstein-Quevedo L, Garcia-Hernandez ML, Camacho-Arroyo I, et al. Telomerase activity in well-differentiated papillary thyroid carcinoma correlates with advanced clinical stage of the disease. Endocr Pathol 14:213-219, 2003.
16. Nakayama J, Tahara H, Tahara E, et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 18:65-68, 1998.
17. Yashima K, Milchgrub S, Gollahon LS, et al. Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma. Cancer Res 4:229-234, 1998.
18. Ramakrishnan S, Eppenberger U, Mueller H, Shinkai Y, Narayanan R. Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res 58:622-625, 1998.
19. Trulsson LM, Velin AK, Herder A, Soderkvist P, Ruter A, Smeds S. Telomerase activity in surgical specimens and fine-needle aspiration biopsies from hyperplastic and neoplastic human thyroid tissues. Am J Surg 186:83-88, 2003.
20. Matthews P, Jones CJ, Skinner J, Haughton M, de Micco C, Wynford-Thomas D. Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications. J Pathol 194:183-193, 2001.
21. Zeiger MA, Smallridge RC, Clark DP, et al. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Surgery 126:1195-1198, 1999.
22. Umbricht CB, Saji M, Westra WH, Udelsman R, Zeiger MA, Sukumar S. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma. Cancer Res 57:2144-2147, 1997.
23. Kawakami Y, Kitamoto M, Nakanishi T, et al. Immunohistochemical detection of human telomerase reverse transcriptase in human liver tissues. Oncogene 19:3888-3893, 2000.
24. Kumaki F, Kawai T, Hiroi S, et al. Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas. Hum Pathol 32:188-195, 2001.
25. Kumaki F, Kawai T, Churg A, et al. Expression of telomerase reverse transcriptase (TERT) in malignant mesotheliomas. Am J Surg Pathol 26:365-370, 2002.
26. Tahara H, Yasui W, Tahara E, et al. Immunohistochemical detection of human telomerase catalytic component hTERT in human colorectal tumour and non tumour tissue sections. Oncogene 18:1561-1567.
27. Iczkowski KA, Pantazis CG, McGregor DH, Wu Y, Tawfik Ossama W. Telomerase reverse transcriptase subunit immunoreactivity - a marker for high-grade prostate carcinoma. Cancer 95:2487-2493, 2002.
28. Isobe K, Yashiro T, Omura S, et al. Expression of the human telomerase reverse transcriptase in pheochromocytoma and neuroblastoma tissues. Endocr J 51:47-52, 2004.
29. Hruban RH, Huvos AG, Traganos F, Reuter V, Lieberman PH, Melamed MR. Follicular neoplasms of the thyroid in men older than 50 years of age. A DNA flow cytometric study. Am J Clin Pathol 94:527-532, 1990.
30. Brennan MD, Bergstralh EJ, van Heerden JA, McConahey WM. Follicular thyroid cancer treated at the Mayo clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 66:11-22, 1991.
31. Shaha AR, Loree TR, Shah JP. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 18:1136-1138, 1995.